Karen Hodgkin

Karen Hodgkin is an experienced professional in the field of clinical research and operations, currently serving as the Head of Operations for the Oncology Cell Therapy Unit at AstraZeneca since August 2020. Prior to this role, Karen worked as a consultant in advanced therapy development and held significant positions at Cell Medica, including Chief Operating Officer and Senior Vice President of Clinical Development. Karen's career also includes experience as a Clinical Research Consultant and as an International Clinical Research Manager at British Biotech. Educational qualifications include a Diploma in Clinical Science from UWIST Cardiff and a Master of Science in Biopharmacy from Kings College London.